Ago-2-Mediated slicer activity is essential for Anti-Flaviviral efficacy of RNAi

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Chen, Shuiping ^a   Chahar, Harendra S ^a   Abraham, Sojan ^a   Wu, Haoquan ^a   Pierson, Theodore C ^b   Wang, Xiaozhong A ^c   Manjunath, N ^a  

^a Paul L Foster School of Medicine   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; LUCIFERASE; MESSENGER RNA; OLIGONUCLEOTIDE; SMALL INTERFERING RNA; ANTIVIRUS AGENT; ARGONAUTE PROTEIN; MICRORNA;

3' UNTRANSLATED REGION; ARTICLE; CELL LINE; CONTROLLED STUDY; DENGUE VIRUS; EMBRYONIC STEM CELL; ENZYME ASSAY; HELA CELL; NONHUMAN; PROTEIN EXPRESSION; RNA INTERFERENCE; VIRUS REPLICATION; WEST NILE FLAVIVIRUS; CELL CULTURE; DENGUE; GENE SILENCING; GENETICS; HUMAN; METABOLISM; VIROLOGY; WEST NILE FEVER;

WEST NILE VIRUS;

3' UNTRANSLATED REGIONS; ANTIVIRAL AGENTS; ARGONAUTE PROTEINS; CELLS, CULTURED; DENGUE; DENGUE VIRUS; EMBRYONIC STEM CELLS; GENE SILENCING; HELA CELLS; HUMANS; LUCIFERASES; MICRORNAS; OLIGONUCLEOTIDES; RNA INTERFERENCE; RNA, SMALL INTERFERING; VIRUS REPLICATION; WEST NILE FEVER; WEST NILE VIRUS;

EID: 80755126039     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027551     Document Type: Article

References (38)

1. Ghildiyal M, Zamore PD, (2009) Small silencing RNAs: an expanding universe. Nat Rev Genet 10: 94-108.
2. Kim SS, Garg H, Joshi A, Manjunath N, (2009) Strategies for targeted nonviral delivery of siRNAs in vivo. Trends Mol Med 15: 491-500.
3. Lares MR, Rossi JJ, Ouellet DL, (2010) RNAi and small interfering RNAs in human disease therapeutic applications. Trends Biotechnol 28: 570-579.
4. Rossbach M, (2010) Small non-coding RNAs as novel therapeutics. Curr Mol Med 10: 361-368.
5. Carthew RW, Sontheimer EJ, (2009) Origins and Mechanisms of miRNAs and siRNAs. Cell 136: 642-655.
6. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
7. Manjunath N, Wu H, Subramanya S, Shankar P, (2009) Lentiviral delivery of short hairpin RNAs. Adv Drug Deliv Rev 61: 732-745.
8. Yoda M, Kawamata T, Paroo Z, Ye X, Iwasaki S, et al. (2010) ATP-dependent human RISC assembly pathways. Nat Struct Mol Biol 17: 17-23.
9. Su H, Trombly MI, Chen J, Wang X, (2009) Essential and overlapping functions for mammalian Argonautes in microRNA silencing. Genes Dev 23: 304-317.
10. Manjunath N, Kumar P, Lee SK, Shankar P, (2006) Interfering antiviral immunity: application, subversion, hope? Trends Immunol 27: 328-335.
11. DeVincenzo J, Lambkin-Williams R, Wilkinson T, Cehelsky J, Nochur S, et al. (2010) A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci U S A 107: 8800-8805.
12. Potenza N, Papa U, Mosca N, Zerbini F, Nobile V, et al. (2011) Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen. Nucleic Acids Res 39: 5157-5163.
13. Zhang GL, Li YX, Zheng SQ, Liu M, Li X, et al. (2010) Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antiviral Res 88: 169-175.
14. Song L, Liu H, Gao S, Jiang W, Huang W, (2010) Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J Virol 84: 8849-8860.
15. Ahluwalia JK, Khan SZ, Soni K, Rawat P, Gupta A, et al. (2008) Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 5: 117.
16. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, et al. (2007) Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449: 919-922.
17. Otsuka M, Jing Q, Georgel P, New L, Chen J, et al. (2007) Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 27: 123-134.
18. Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, et al. (2005) A cellular microRNA mediates antiviral defense in human cells. Science 308: 557-560.
19. Grundhoff A, Sullivan CS, (2011) Virus-encoded microRNAs. Virology 411: 325-343.
20. Huang J, Wang F, Argyris E, Chen K, Liang Z, et al. (2007) Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med 13: 1241-1247.
21. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, et al. (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141: 129-141.
22. Huang S, Wu S, Ding J, Lin J, Wei L, et al. (2010) MicroRNA-181a modulates gene expression of zinc finger family members by directly targeting their coding regions. Nucleic Acids Res 38: 7211-7218.
23. Qin W, Shi Y, Zhao B, Yao C, Jin L, et al. (2010) miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS One 5: e9429.
24. Rigoutsos I, (2009) New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites. Cancer Res 69: 3245-3248.
25. Kim SS, Ye C, Kumar P, Chiu I, Subramanya S, et al. (2010) Targeted delivery of siRNA to macrophages for anti-inflammatory treatment. Mol Ther 18: 993-1001.
26. Kumar P, Lee SK, Shankar P, Manjunath N, (2006) A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med 3: e96.
27. Subramanya S, Kim SS, Abraham S, Yao J, Kumar M, et al. (2010) Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production. J Virol 84: 2490-2501.
28. Ye C, Abraham S, Wu H, Shankar P, Manjunath N, (2011) Silencing early viral replication in macrophages and dendritic cells effectively suppresses flavivirus encephalitis. PLoS One 6: e17889.
29. Eulalio A, Behm-Ansmant I, Izaurralde E, (2007) P bodies: at the crossroads of post-transcriptional pathways. Nat Rev Mol Cell Biol 8: 9-22.
30. Rehwinkel J, Behm-Ansmant I, Gatfield D, Izaurralde E, (2005) A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing. RNA 11: 1640-1647.
31. Emara MM, Brinton MA, (2007) Interaction of TIA-1/TIAR with West Nile and dengue virus products in infected cells interferes with stress granule formation and processing body assembly. Proc Natl Acad Sci U S A 104: 9041-9046.
32. Eulalio A, Behm-Ansmant I, Schweizer D, Izaurralde E, (2007) P-body formation is a consequence, not the cause, of RNA-mediated gene silencing. Mol Cell Biol 27: 3970-3981.
33. Cheloufi S, Dos Santos CO, Chong MM, (2010) Hannon GJ A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature 465: 584-589.
34. Moens U, (2009) Silencing viral microRNA as a novel antiviral therapy? J Biomed Biotechnol pp. 419539.
35. Ehsani A, Saetrom P, Zhang J, Alluin J, Li H, et al. (2010) Rational design of micro-RNA-like bifunctional siRNAs targeting HIV and the HIV coreceptor CCR5. Mol Ther 18: 796-802.
36. Nathans R, Chu CY, Serquina AK, Lu CC, Cao H, et al. (2009) Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell 34: 696-709.
37. Chable-Bessia C, Meziane O, Latreille D, Triboulet R, Zamborlini A, et al. (2009) Suppression of HIV-1 replication by microRNA effectors. Retrovirology 6: 26.
38. Pierson TC, Sanchez MD, Puffer BA, Ahmed AA, Geiss BJ, et al. (2006) A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology 346: 53-65.